Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections. At the core of our work is Vicebio’s groundbreaking Molecular Clamp Technology, which locks viral proteins in their optimal conformation. This innovation enables our vaccines to deliver a unique combination of broad protection, ready-to-use administration, and convenient manufacturing. Our lead program is a best-in-class multivalent vaccine targeting five respiratory diseases, positioning Vicebio as a leader in multipathogen respiratory vaccines.
| Website | https://www.vicebio.com |
| Employees | 23 (10 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Vaccine Development, Viral Vaccines, Vaccine Technology, Viral Research, Vaccine Research, Protein Engineering, Infectious Disease, Vaccine Production, Immunology, Biotechnology, Pharmaceutical |
| Competitors | Thermo Fisher Scientific, Amgen, Syngenta, Agilent Technologies, Illumina, Corteva Agriscience, QIAGEN, Novozymes, Benson Hill, Zymergen, Inc. +35 more (view full list) |
Looking for a particular Vicebio employee's phone or email?
Vicebio Questions
Wim Tiest is the CIO of Vicebio.
10 people are employed at Vicebio.
Top Vicebio Employees
-
32
-
Sandra Branson
Chief HR Officer at Vicebio
Zaventem, BE23 -
Koen Huygens
Chief Quality Officer at Vicebio
Antwerp, BE5+1 -
Morgan Bodson
CMC Senior Manager at Vicebio
Namur, Wallonia, BE1 -
Javier Ruiz Guiñazú
Chief R and D Officer at Vicebio
Ottignies-Louvain-la-Neuve, Wallonia, BE2 -
Marie-Julie Dewez
Associate scientist at Vicebio
Eghezee, WAL, BE1 -
Julie Dutton
Project Management Consultant at Vicebio
Toowoomba, QLD, AU1 -
Briony Joyce
Postdoctoral Research Fellow at Vicebio
Brisbane City, QLD, AU1
Related Companies
